About Cagrilintide
Cagrilintide is a long-acting amylin analog that suppresses gastric emptying and reduces food intake. Combined with Semaglutide as CagriSema, drives 17.1% weight loss at 32 weeks.
Reported benefits
- Slows gastric emptying for sustained satiety
- Stacks with Semaglutide for 17.1% loss at 32 weeks
- Once-weekly subcutaneous dosing
Research citations
- Lau et al. 2021 - Lancet
- Enebo et al. 2021 - Lancet
How Cagrilintide fits the category
Cagrilintide sits inside the Best Peptides for Weight Loss category. For the full ranking and head-to-head comparisons, read Best Peptides for Weight Loss.

